Sven Wehrwein - Nov 24, 2025 Form 4 Insider Report for AtriCure, Inc. (ATRC)

Role
Director
Signature
/s/ Sven Wehrwein
Stock symbol
ATRC
Transactions as of
Nov 24, 2025
Transactions value $
-$177,078
Form type
4
Date filed
11/26/2025, 04:43 PM
Previous filing
Aug 26, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
WEHRWEIN SVEN Director 4877 EAST LAKE HARRIET PARKWAY, MINNEAPOLIS /s/ Sven Wehrwein 2025-11-26 0001205069

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRC Common Stock Options Exercise $100K +5.03K +14.64% $19.95 39.4K Nov 24, 2025 Direct
transaction ATRC Common Stock Sale -$188K -5.03K -12.77% $37.32 34.4K Nov 24, 2025 Direct F1
transaction ATRC Common Stock Options Exercise $99.1K +4.97K +14.45% $19.95 39.3K Nov 25, 2025 Direct
transaction ATRC Common Stock Sale -$189K -4.97K -12.63% $38.00 34.4K Nov 25, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATRC Non-qualified Stock Option (right to buy) Options Exercise $0 -5.03K -14.38% $0.00 30K Nov 24, 2025 Non-qualified Stock Option (right to buy) 5.03K $19.95 Direct F2
transaction ATRC Non-qualified Stock Option (right to buy) Options Exercise $0 -4.97K -16.57% $0.00 25K Nov 25, 2025 Non-qualified Stock Option (right to buy) 4.97K $19.95 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $37.32 to $38.00 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 These options were granted on November 11, 2016. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.